Author: healthylife7

There’s something primordially satisfying about watching a big-screen dinosaur get the what-for from the business end of a just-loaded shotgun. The recent run of Jurassic Park movies sometimes seems to have lost this primal pleasure, replacing it with ho-hum computer-generated spectacle and cheap nostalgic callbacks to the franchise’s better days. They’ve forgotten that the franchise…

Read More

This week, the U.K.’s healthcare regulatory body approved Eli Lilly’s (NYSE: LLY) weight loss drug orforglipron, sold as Foundayo, for weight management and type 2 diabetes. Unlike Lilly’s other weight loss drug, Zepbound, Foundayo is a pill, not an injectable medication — and that’s a fresh piece of good news for investors

Read More

The approval of an oral version of Wegovy in the EU could broaden the impact of GLP-1 medicines on the food and beverage industry, as easier access to weight-management treatment potentially brings more consumers into a market already showing changes in appetite, purchasing behavior, and nutritional priorities

Read More

Emerging and re-emerging infectious diseases continue to pose a significant threat to public health, livelihoods and economic stability worldwide. More than 60% of emerging infectious diseases that are reported globally come from animals, both wild and domestic, highlighting the importance of effective collaboration across human health, animal health and environmental sectors. Recent outbreaks have demonstrated…

Read More